Oct 03, 2019 8:30am EDT Glauconix Biosciences and University of Mississippi to Present Research Data Related to Emerald Bioscience’s Glaucoma Drug Candidate, NB1111, at 2019 American Academy of Ophthalmology Annual Meeting
Aug 27, 2019 8:30am EDT Emerald Bioscience to Participate in Investment and Scientific Conferences in September
Aug 26, 2019 8:30am EDT Emerald Bioscience Appoints Chief Medical Officer and Executive Director, Clinical Operations
Aug 13, 2019 8:30am EDT Emerald Bioscience Starts Australian Operation Ahead of Planned Glaucoma Study
Jun 19, 2019 7:00am EDT Emerald Bioscience to Participate in 29th Annual International Cannabinoid Research Symposium (ICRS)
Jun 04, 2019 8:00am EDT Emerald Bioscience’s NB2222 Exhibits Superior Ocular Permeation into Multiple Compartments of the Eye Compared to Cannabidiol
May 29, 2019 8:00am EDT Emerald Bioscience Secures “All Fields” Licenses for Cannabinoid Derivatives Developed by University of Mississippi
May 13, 2019 8:00am EDT Emerald Bioscience to Participate at the CannaStocks 2019 Q1 Investor Conference